Edap TMS SA (EDAP)
2.52
-0.11
(-4.18%)
USD |
NASDAQ |
Nov 14, 16:00
Edap TMS Cash and Short Term Investments (Quarterly): 28.46M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 28.46M |
| June 30, 2024 | 32.38M |
| March 31, 2024 | 41.51M |
| December 31, 2023 | 48.05M |
| September 30, 2023 | 50.51M |
| June 30, 2023 | 55.78M |
| March 31, 2023 | 63.58M |
| December 31, 2022 | 67.71M |
| September 30, 2022 | 67.16M |
| June 30, 2022 | 48.40M |
| March 31, 2022 | 51.90M |
| December 31, 2021 | 53.42M |
| September 30, 2021 | 52.67M |
| June 30, 2021 | 53.50M |
| March 31, 2021 | 28.58M |
| December 31, 2020 | 30.38M |
| September 30, 2020 | 23.40M |
| June 30, 2020 | 17.66M |
| March 31, 2020 | 20.35M |
| December 31, 2019 | 23.40M |
| September 30, 2019 | 19.33M |
| June 30, 2019 | 18.48M |
| March 31, 2019 | 20.84M |
| December 31, 2018 | 22.26M |
| September 30, 2018 | 18.52M |
| Date | Value |
|---|---|
| June 30, 2018 | 19.89M |
| March 31, 2018 | 22.37M |
| December 31, 2017 | 24.00M |
| September 30, 2017 | 21.25M |
| June 30, 2017 | 21.22M |
| March 31, 2017 | 21.72M |
| December 31, 2016 | 23.25M |
| September 30, 2016 | 21.13M |
| June 30, 2016 | 24.40M |
| March 31, 2016 | 16.47M |
| December 31, 2015 | 15.94M |
| September 30, 2015 | 12.46M |
| June 30, 2015 | 13.29M |
| March 31, 2015 | 12.22M |
| December 31, 2014 | 14.76M |
| September 30, 2014 | 14.03M |
| June 30, 2014 | 17.46M |
| March 31, 2014 | 8.861M |
| December 31, 2013 | 10.61M |
| September 30, 2013 | 8.689M |
| June 30, 2013 | 9.608M |
| March 31, 2013 | 9.339M |
| December 31, 2012 | 10.68M |
| September 30, 2012 | |
| June 30, 2012 | 10.04M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
17.66M
Minimum
Jun 2020
67.71M
Maximum
Dec 2022
42.94M
Average
48.23M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Genfit SA | 85.99M |
| Cellectis SA | 260.89M |
| Adaptimmune Therapeutics PLC | 214.79M |
| Akari Therapeutics PLC | 4.177M |
| Biodexa Pharmaceuticals PLC | 6.394M |